National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
call now for more information . . . 1-800-4-CANCER
DMIST Digital Mammographic Imaging Screening Trial
DMIST, the Digital Mammographic Imaging Screening Trial, is a research study sponsored by the U.S. National Cancer Institute to compare digital mammography to conventional screen-film mammography.
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Colorectal Cancer Drugs Require Careful Patient Selection

Cetuximab for Advanced Lung Cancer

Past Highlights
DMIST Updates

Information from the NCI Press Office
Digital Mammography Trial Results Announced: Women with Dense Breasts, Women Younger than 50, and Those Who are Perimenopausal May Benefit from Digital Mammograms
(Posted: 09/16/2005) - A new study from the NCI shows that currently available screening methods such as transvaginal ultrasound and testing for a protein biomarker called CA-125, alone or in combination, can detect ovarian cancer but can also produce many false-positive test results, causing needless surgery. Questions and Answers; "Fast Facts": The DMIST Study Results

Digital vs. Film Mammography in the Digital Mammographic Imaging Screening Trial (DMIST): Questions and Answers
(Posted: 09/16/2005) - DMIST showed that, for the entire population of women studied, digital and film mammography had very similar screening accuracy.

"Fast Facts": The DMIST Study Results
(Posted: 09/16/2005) - The Digital Mammographic Screening Trial (DMIST) showed that, for the entire population of women studied, digital and film mammography had very similar screening accuracy.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov